3-[[(1R,2R)-2-(1-哌啶基)环己基]氨基]-4-[[4-(三氟甲基)苯基]氨基]-3-环丁烯-1,2-二酮, 3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(triflu

利奈唑胺杂质33, Linezolid Impurity 33

膦酸肌酐(磷酸肌酸), Fosfocreatinine (Phosphatecreatinine)

4-(三氟甲氧基)哌啶盐酸盐, 4-(Trifluoromethoxy)piperidinehydrochloride

(3R,4R)-3-羟基-4-(羟甲基)吡咯烷-1-羧酸叔丁酯, tert-Butyl (3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-

2-氨基-2-(3-甲基氧杂环丁烷-3-基)乙酸, 2-Amino-2-(3-methyloxetan-3-yl)acetic acid

(S)-4-苯基-2-(喹啉-2-基)-4,5-二氢噁唑, (S)-Ph-quinox

1-(3-(甲硫基)苯基)哌嗪, 1-(3-(Methylthio)phenyl)piperazine

1-甲氧基-4-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)环己-3-烯羧酸甲酯, Methyl 1-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2

rel-(3R,4S)-1-(叔丁氧基羰基)-4-苯基吡咯烷-3-羧酸, rel-(3R,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-3-ca